Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.

× No keyword cloud information.

51 in total

Review 1. Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review.

Authors: Boris Arbit; Jonathan C Hsu
Journal: Clin Cardiol Date: 2015-07-14 Impact factor: 2.882

2. A mouse bleeding model to study oral anticoagulants.

Authors: Dougald M Monroe; Maureane Hoffman
Journal: Thromb Res Date: 2014-05 Impact factor: 3.944

3. Interrupting anticoagulation in patients with nonvalvular atrial fibrillation.

Authors: Scott W Yates
Journal: P T Date: 2014-12

4. Management of dabigatran-induced bleeding with continuous venovenous hemodialysis.

Authors: Suman Paul; Danae Hamouda; Rohini Prashar; Chiamaka Mbaso; Abdur Khan; Abdulmonam Ali; Sarthi Shah; Ragheb Assaly
Journal: Int J Hematol Date: 2015-01-30 Impact factor: 2.490

5. Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.

Authors: Jennifer L Aron; Robert Gosselin; Stephan Moll; Charles F Arkin; Simon Mantha
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

6. LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?

Authors: Alex Y Tan; Michael A Rosenberg
Journal: Clin Med Rev Vasc Health Date: 2013-06-20

Review 7. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors: Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal: Drugs Date: 2015-06 Impact factor: 9.546

8. Laboratory tests during direct oral anticoagulant treatment.

Authors: Armando Tripodi; Simon Braham; Marco Moia
Journal: Intern Emerg Med Date: 2014-02-04 Impact factor: 3.397

Review 9. The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.

Authors: Saleh Rachidi; Ehab Saad Aldin; Charles Greenberg; Barton Sachs; Michael Streiff; Amer M Zeidan
Journal: Expert Rev Hematol Date: 2013-12 Impact factor: 2.929

10. Pharmacometric characterization of dabigatran hemodialysis.

Authors: Karl-Heinz Liesenfeld; Alexander Staab; Sebastian Härtter; Stephan Formella; Andreas Clemens; Thorsten Lehr
Journal: Clin Pharmacokinet Date: 2013-06 Impact factor: 6.447